395868008: Rivastigmine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Acetylcholinesterase inhibitor\...

\Centrally acting acetylcholinesterase inhibitor\Rivastigmine (substance)

\Reversible anticholinesterase\Rivastigmine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Parasympathomimetic agent (substance)\Acetylcholinesterase inhibitor\Centrally acting acetylcholinesterase inhibitor\Rivastigmine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Parasympathomimetic agent (substance)\Acetylcholinesterase inhibitor\Reversible anticholinesterase\Rivastigmine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Rivastigmine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Carbamate (substance)\Carbamate ester (substance)\Phenylcarbamate (substance)\Rivastigmine (substance)

\Ester\Carbamate ester (substance)\Phenylcarbamate (substance)\Rivastigmine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rivastigmine (substance)	Is a	Substance with cholinesterase inhibitor mechanism of action	false	Inferred relationship	Some
Rivastigmine (substance)	Is a	Reversible anticholinesterase	true	Inferred relationship	Some
Rivastigmine (substance)	Is a	agent antidémence	false	Inferred relationship	Some
Rivastigmine (substance)	Is a	Phenylcarbamate (substance)	true	Inferred relationship	Some
Rivastigmine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Acetylcholine receptor agonist (disposition)	false	Inferred relationship	Some
Rivastigmine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cholinesterase inhibitor	false	Inferred relationship	Some
Rivastigmine (substance)	Is a	Centrally acting acetylcholinesterase inhibitor	true	Inferred relationship	Some
Rivastigmine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Centrally acting acetylcholinesterase inhibitor (disposition)	true	Inferred relationship	Some
Rivastigmine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reversible anticholinesterase	true	Inferred relationship	Some
Rivastigmine (substance)	Is a	Central nervous system agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing rivastigmine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine 2mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine tartrate (substance)	Is a	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine 4.6mg/24 hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Rivastigmine 9.5mg/24 hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Product containing rivastigmine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Product containing rivastigmine in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine (substance)	Inferred relationship	Some
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine tartrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Rivastigmine (substance)	Inferred relationship	Some
Product containing rivastigmine in transdermal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Product containing only rivastigmine in transdermal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine 192 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine 192 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine 396 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine (substance)	Inferred relationship	Some	1
Rivastigmine 396 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rivastigmine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469808018	Rivastigmine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489506019	Rivastigmine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
59461000195114	rivastigmina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
838551000172113	rivastigmine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
74771000195112	Rivastigmin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module